The latest update is out from Neurogene (NGNE).
Neurogene Inc. has struck new employment deals with its top executives, setting significant compensation packages that include a mix of salary, bonuses, and equity awards. CEO Rachel McMinn will start with a $595,000 annual salary, eligible for a 55% performance bonus, while President and CFO Christine Mikail’s salary begins at $515,000 with a 45% bonus target. Both have severance terms ensuring a financial cushion if they’re terminated without cause or under certain conditions tied to company control changes, such as lump sum payments and extended healthcare. These agreements reflect the company’s commitment to competitive executive compensation in the dynamic financial landscape.
See more data about NGNE stock on TipRanks’ Stock Analysis page.
